Jerusalem
Jerusalem
Jerusalem, Israel, Israel12 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Active, not recruiting | Phase 3 | 2026-08-26 | NCT05625399 | |
| Evaluating the Safety and Efficacy of AMOR-1 as a Treatment for Hypocalcemia Associated With Hypoparathyroidism in Adults | Hypocalcemia, Nutritional and Metabolic Diseases, Water-Electrolyte Imbalance, calcium metabolic disease, endocrine system disorder, hypoparathyroidism, metabolic disease, parathyroid gland disorder | Active, not recruiting | Phase 2 | 2026-08-14 | NCT06547151 | |
| A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies | neoplasm | Recruiting | Phase 1 | 2026-08-12 | NCT06759649 | |
| Dipyridamole for Early-Onset Preeclampsia: A Pilot Study of Feasibility, Pharmacokinetics, and Biological Effects | Female Urogenital Diseases and Pregnancy Complications, Urogenital Diseases, cardiovascular disorder, hypertension, pregnancy-induced, hypertensive disorder, preeclampsia, pregnancy disorder, vascular disorder | Not yet recruiting | Phase 1 / Phase 2 | 2026-07-31 | NCT07738562 | |
| Lifestyle Intervention to Reduce the Risk of Sarcopenia in Adults With Diabetes & Obesity Treated With Semaglutide | Atrophy, Body Weight, Neurologic Manifestations, Neuromuscular Manifestations, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, muscular atrophy, nervous system disorder, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus | Recruiting | Not applicable | 2026-07-21 | NCT06497595 | |
| Obstetric Risk Assessment & Cesarean-delivery in Labor Estimation Using Artificial Intelligence | Cesarean Section Rate; Labor, Obstetric; Pregnancy | Recruiting | Not applicable | 2026-05-22 | NCT07430358 | |
| A Study to Evaluate the MNV-201 in Patients With Low Risk MDS | Hemic and Lymphatic Diseases, anemia, bone marrow disorder, hematologic disorder, myelodysplastic syndrome | Recruiting | Phase 1 | 2025-10-01 | NCT06465160 | |
| Collection of Samples of Bone Marrow Aspiration From Patients With Myelodysplastic Syndrome | Hemic and Lymphatic Diseases, bone marrow disorder, hematologic disorder, myelodysplastic syndrome | Active, not recruiting | Not stated | 2025-06-22 | NCT06144515 | |
| Use of Existing Fibroblast Cells to Convert to Induced Pluripotent Stem Cells | Healthy Male Newborns; Pregnant, Healthy Females | Recruiting | Not stated | 2025-03-19 | NCT00801372 | |
| The Expression of CD24 "do-not-eat-me" Signal in Cholangiocarcinoma | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, cholangiocarcinoma, epithelial neoplasm, liver disorder, neoplasm | Active, not recruiting | Not stated | 2025-03-14 | NCT06707025 | |
| Development of IPS from Donated Somatic Cells of Patients with Neurological Diseases | Alzheimer disease, Cognition Disorders, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA repair disease, Dyskinesias, Eye Diseases, Hereditary, Huntington disease, Muscular Disorders, Atrophic, Neurologic Manifestations, Nutritional and Metabolic Diseases, Parkinson disease, Primary Immunodeficiency Diseases, Riley-Day syndrome, Spinocerebellar Ataxias, TDP-43 proteinopathy, amyotrophic lateral sclerosis, atactic disorder, non-human animal, ataxia telangiectasia, autonomic nervous system disorder, basal ganglia disorder, brain disorder, cardiovascular disorder, central nervous system disorder, central nervous system malformation, cerebellar ataxia, cerebellar disorder, choreatic disease, cognitive disorder, dementia, eye disorder, hereditary disease, hereditary sensory and autonomic neuropathy, immune system disorder, inborn error of immunity, inherited neurodegenerative disorder, inherited retinal dystrophy, macular degeneration, metabolic disease, motor neuron disorder, movement disorder, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neurocutaneous syndrome, neurodegenerative disease, neuromuscular disease, parkinsonian disorder, peripheral nervous system disorder, polyneuropathy, primary dysautonomia, proteostasis deficiencies, psychiatric disorder, retinal degeneration, retinal disorder, retinitis pigmentosa, spinal cord disorder, spinal muscular atrophy, synucleinopathy, tauopathy, telangiectasis, vascular disorder | Recruiting | Not stated | 2025-03-04 | NCT00874783 | |
| First Line Therapy for Extensive SCLC Patients, Treated with Chemo+Keytruda Followed by Keytuda+Trodelvy | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2025-01-17 | NCT06667167 |